Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
The Medicines Company · Thrombocytopenia · Thrombosis
Phase 3
Completed
88
2018-11
Industry sponsor intelligence
The Medicines CompanyClinical Pipeline.
Lead-sponsor view of The Medicines Company's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 8
- Recruiting
- 0
- Active
- 0
- Completed
- 5
- Results posted
- 4
- Avg enrollment
- 578
Pipeline overview
Programs by phase and activity.
Velocity
The Medicines Company trials by start year
Study start year · indexed snapshot
Development
Trials by phase
7phase labels
Early Phase 10
Phase 10
Phase 20
Phase 36
Phase 41
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Bivalirudin → | 8 | 0 | 0 | 6 | 1 | 0 |
| Eptifibatide → | 1 | 0 | 0 | 1 | 0 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
NCT IDStudyPhase / statusEnrollmentUpdated
Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
The Medicines Company · Severe Aortic Stenosis · Transcatheter Aortic Valve Replacement
Phase 3
Completed
803
2017-04
European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial
The Medicines Company · Acute Coronary Syndrome
Phase 3
Completed
2,198
2016-02
Utilisation of Angiox® in European Practice
The Medicines Company · Stable Angina (SA) · NSTE-ACS (NSTEMI and UA)
Not applicable
Completed
2,019
2012-01
Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)
The Medicines Company · Cardiovascular Disease · Coronary Artery Bypass Surgery
Phase 3
Completed
150
2012-01
Search sponsor records
All The Medicines Company studies.
This page groups studies where The Medicines Company is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
8 matching studies
Last registry update first
Recent updates
Latest registry movement.
NCT00759083Bivalirudin PCI Registry in Heparin Induced Thrombocytopenia/Heparin Induced Thrombocytopenia and Thrombosis Syndrome (HIT/HITTS) PatientsOct 19, 2020NCT00073580Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)Nov 30, 2018NCT02565147Bivalirudin Infusion for Ventricular Infarction LimitationOct 5, 2018NCT01913483ENDOvascular Interventions With AngioMAX: The ENDOMAX TrialMay 30, 2017NCT01651780Open-label, Randomized Trial in Participants Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFHApr 7, 2017NCT01087723European Ambulance Acute Coronary Syndrome (ACS) Angiography TrialFeb 12, 2016NCT01011504Utilisation of Angiox® in European PracticeJan 19, 2012NCT00079586Comparing Angiomax to Heparin With Protamine in Patients Undergoing Cardiopulmonary Bypass (CPB)Jan 5, 2012